News Center

Home page

Peak Report

News reports

Deep cultivation of chemical industry to do national industry

Release time:

2020-07-22

sailing against the current deep ploughing chemistry doing national industry

kang litao

general manager of Shanghai beika pharmaceutical technology co., ltd. chemical industry is very ill recently. From Tianjin Port to Lianyungang Port, the Yancheng Tianjiayi 3.21 accident pushed the chemical safety problem to its peak. The accident reflected many problems, such as the storage and management of multi-nitrocellulose, the control of high-pressure hydrogenation reaction, the construction of coal to gas and special operations, the storage of hazardous waste warehouses, the legal representative being the workshop director, the training and loose management of personnel, etc., which made people stand creepy. A week later, Yancheng City announced the permanent closure of Xiangshui Park. At the same time, the thermal power plant of Yancheng Binhai Development Zone, which is 15 kilometers away from Xiangshui 30 , cut off steam from all enterprises. More than 70 enterprises in production were all shut down. The resumption time is unknown and is expected to be at least half a year. At the same time, the park also requested that only 15-20 of the existing 130 enterprises remain.

I went to see the past two factories from Zhejiang and Shanghai, both of which are in the process of 2 project construction. As the investment scale is not hundreds of millions and the land area is less than 100 mu, there is no possibility of further construction. The invested in the early stage has been hit by Shui Piao. At the same time, a large number of factory managers are moving to northern Shaanxi, Inner Mongolia, Ningxia and Gansu. In the public opinion and ideological trend, the local people and outsiders are also full of hostility and criticism to the chemical industry, magnifying the environmental harm of the factory, comparing our factory to a scourge, and the chemical industry is in danger in China.

Why is this happening? As the head of two chemical plants, I often ask myself.

In recent years, I have visited at least 50 parks in China. There are three reasons for this: firstly, investors and shareholders are eager for quick success and instant benefits. A certain variety is launched in a hurry, while investors do not understand the operation characteristics of the chemical, equipment and chemical industries, which leads to being abandoned or shut down halfway due to process problems, industry cycle shutdown, safety and environmental protection, etc, to the integration of resources to bring huge waste and negative impact. The second is the lack of overall planning and operation of the industry. The chemical and chemical industry and its derived pharmaceuticals, pesticides, materials, fuels, electronic chemicals, daily chemicals, etc., have their own development laws, especially the parts involved in chemical reactions, which are technology-intensive, labor-intensive (under the condition that the degree of automation is not high), investment-intensive and resource-intensive industries, the factory needs continuous investment ability and improvement space in personnel, variety, technology, safety, environmental protection and capital, so as to make the factory a global standardized factory. The third is the market and innovation strategy. As the basic and strategic industry of a country, chemistry level determines the industrial level and equipment level of a country. How to set its own benchmark in the world's industrial forest, innovation ability is very important. What does innovation rely on? Rely on strategy and people, strategy determines the market positioning, by people to complete innovation and leadership, which is our industry is now the most lack of two points.

Now, facing the predicament of the chemical and chemical industry, I hope to change the attitude of more people around me towards chemistry in 5-10 and devote myself to chemistry. I also hope to sail against the current in my own work, cultivate chemistry deeply and strengthen the national industry of chemistry. North Carolina Pharmaceutical is an innovative and technological enterprise engaged in chemical pharmacy and pesticide. It has 300 employees and 400 mu factory. It has the full support of its parent company Jianfeng Group and Jianfeng Pharmaceutical. I hope to be a strong chemical and chemical enterprise with my own ideas and actions. Therefore, I must work hard in five aspects:

adhere to political correctness. The chemical industry must not tolerate any opportunism and cutting corners. It must be transparent and open in the specified areas. Employees should be informed and informed, and government and public information should be disclosed and jointly supervised.

Scientific Outlook on Development. Don't rush for success, fully demonstrate and complete due procedures from research and development, project initiation, drug application, safety assessment and environmental assessment, GMP production, market launch and other aspects, strive to become a benchmark enterprise in the industry, maintain the potential to become a leader in the industry, develop green chemistry ecology, and seize due opportunities.

Forward-looking talent view. In our industry, from the quality and research and development of drugs to the safety, environmental protection and automation of the site, all inputs must be controlled by people with corresponding capabilities. How to create an environment to retain talent? In addition to the change of the social environment and the promotion of the overall industry, we also need to give enough care to our employees. In addition to safety and environmental protection, there are also all-round care for life, entertainment, learning and education, marriage and family. At present, we have done a lot of work in joint school training, transportation and accommodation, leisure and entertainment, and we will continue to work hard to give everyone enough care and sense of security.

Fundamental changes in equipment and automation. Most factories are still kettle-type reactions, relying on crowd tactics and high-intensity shifts to save costs, but this has lagged far behind the fully automated production and continuous reaction processes of the same industry abroad, and we have lagged behind in design. Therefore, what needs to be considered now is how to keep materials away from the air, keep employees away from materials, create a good working environment for employees, and at the same time improve the quality and treatment of employees, so as to become a real industrial 3.0-4.0 enterprise.

Further strengthen industry research and integration. At present, many industries have overcapacity, and the integration of many industries after non-standard brings huge opportunities, so we need to study the global market in depth. Ten years of sharpening a sword, leaving enough time for planning and integration is very necessary. We not only want to make profits, but also have strategies and coordination to become the backbone of the chemical industry.

This year marks the 80th anniversary of "May 4th " Movement 100#. I also call on everyone to revitalize the fine chemical national industry with the May 4th spirit of "Patriotism, Progress, Democracy, Science " , so as to make our food, clothing, housing and transportation better, better serve our great health and make the Chinese nation stronger.

More information

Yunnan peak through the safety standard secondary acceptance

On March 21, Yunnan Jianfeng Cement Company successfully passed the evaluation and acceptance of secondary enterprises for safety production standardization. On the same day, a review team composed of leaders of the Yunnan Provincial Work Safety Supervision Bureau and relevant experts reviewed the implementation of the establishment of Yunnan Jianfeng safety production standardization secondary enterprises. According to the 13 elements involved in the "Standard for Assessment and Rating of Safety Production Standardization in Cement Enterprises", the review team conducted strict assessment and scoring item by item through grouping to check the site and review the data, and finally determined that Yunnan Peak passed the standard acceptance of safety standardization secondary enterprises. Yunnan Jianfeng has always attached great importance to safety production. After passing the three-level safety standard enterprise review in 2015, in order to raise the level of enterprise safety management to a new level, in 2016, it began to create secondary safety standardization. Over the past year, Yunnan Jianfeng has insisted on taking the creation of secondary safety standards as the top priority of production and operation management, and has formulated an implementation plan for production safety standardization in accordance with the requirements of national standardization norms. the content covers production safety responsibility system, education and training, safety inspection, safety facilities management and other safety production management standards, systems and post safety operation procedures, while further strengthening daily safety inspection and regularly organizing emergency plan drills, strengthen the investigation and rectification of potential safety hazards and the supervision of important hazard sources, and further consolidate the foundation of enterprise safety production management. After the review, Zhou Jiping, general manager of Yunnan Jianfeng, said that Yunnan Jianfeng will take this standard as a new starting point. On the basis of consolidating the accident-free achievements in production safety for two consecutive years, it will conscientiously implement the main responsibility of production safety and cultivate

2020

07-30

Pharmaceutical Company Invests in Beihui Bio-Peak Pharmaceutical Plate to Expand its Territory

News from our newspaper On February 28, the 10th meeting of the 9th Board of Directors of the Group Company reviewed and approved the "Proposal on Foreign Investment of Subsidiaries" and the "Proposal on Authorizing the Chairman of the Board of Directors." On the same day, Jianfeng Pharmaceutical signed the "Agreement on Capital Increase and Share Transfer of Beijing Huibaoyuan Biotechnology Co., Ltd." and the "Performance Commitment Compensation Agreement" with relevant parties. It is planned to use Beijing Huibaoyuan Biotechnology Co., Ltd. (Beihui Biotechnology) and its holding subsidiary Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. (Guanghui Pharmaceutical) as a platform to jointly carry out new drug research and development, drug production and operation and other pharmaceutical business cooperation. Beihui Biological formerly known as Beijing Huibaoyuan Biotechnology Co., Ltd. The company has strong capabilities in new drug research and development. The actual controller is James Zhou (Zhou Hua), a returned entrepreneurial Ph.D. from Yale University in the United States, and hired Professor Zheng Yongqi from Yale University in the United States as the director of the Huibaoyuan Science and Technology Committee, focusing on anti-tumor and liver disease research. Through the cooperation with Yale University, we have obtained the patent authorization and commercial development license of the new anti-cancer chemical drug trasatabine (trokacitabine)(which has obtained the national new drug clinical approval in August 2016), the anti-hepatitis B chemical drug Crevudine (Clevudine). Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd., a subsidiary of Beihui Biology, is located in the third international park "China-Malaysia Qinzhou Industrial Park" jointly built by the Chinese government and foreign governments in Guangxi. It covers an area of 214.46 mu and has production workshops for multiple dosage forms such as percolation, tincture, solid preparations and liquid preparations.

2020

07-31

Peak health marketing and a new "play"

Building a New System, Flattening Management, Spike Health Marketing, New "Fit" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original division model, combines all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)

2020

07-31

Peak health marketing and a new "play"

Building a New System, Flattening Management, Spike Health Marketing, New "Way to Work" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original business model, unifies all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)

2020

07-31

Accident-free factory creation enters "second season"

At the beginning of the new year, a major "highlight" of the company's safety and environmental protection management in recent years-the "second quarter" of the establishment of a safety and environmental protection accident-free factory has also begun. Safety and environmental protection accident-free factory creation activities are an important measure for the company to improve the level of on-site management. The first phase of the activity will start on January 1, 2014 and end at the end of 2016 for a period of three years. Since the launch of the activity, all subordinate enterprises of the company have actively organized publicity and training related to safety and environmental protection, strengthened the awareness of safety and environmental protection of all employees, improved the management and operation level of safety and environmental protection; increased investment in safety and environmental protection facilities and equipment; strengthened safety and environmental protection inspection and self-examination and correction of hidden dangers, and timely organized rectification of hidden dangers; strictly assessed the units and relevant responsible persons of the accident, And the accident situation in the group, in order to arouse vigilance and avoid similar accidents. In the past three years, the company's subsidiaries have achieved remarkable results in standardization, safety, and clean operation. Safety and environmental protection accidents have dropped significantly, and no major accidents have occurred, which has effectively promoted the company's safe and civilized production construction. In the 2016 safety and environmental protection accident-free factory establishment assessment conducted a few days ago, a total of 6 units met the accident-free factory standard, of which Yunnan Jianfeng, Jianfeng International Trade and Pharmaceutical Department met the standard for the second consecutive year, and Daye Jianfeng, Qiubin Factory and Cable Company met the standard in the first year. In order to sum up experience and further improve the level of safety and environmental protection management, the Group decided to continue to open

2020

07-31

What will the Chinese Medicine Act bring us?

At the 25th meeting of the Standing Committee of the 12th National People's Congress in December 2016, the the People's Republic of China Chinese Medicine Law (hereinafter referred to as the Chinese Medicine Law) was deliberated and passed, which will come into effect on July 1 this year. As the first comprehensive law that comprehensively and systematically embodies the characteristics of traditional Chinese medicine, the Law of traditional Chinese Medicine clearly stipulates the service of traditional Chinese medicine, the protection and development of traditional Chinese medicine, the training of talents of traditional Chinese medicine, and the scientific research of traditional Chinese medicine. With the change of people's health concept and the continuous innovation of medical mode in recent years, the role of traditional Chinese medicine in health is becoming more and more important. The promulgation of the "Traditional Chinese Medicine Law" has made the development of Chinese medicine more law-based, and it is bound to bring changes to domestic pharmaceutical companies. So, the peak of the pharmaceutical, health products companies will look at the "Chinese Medicine Law", and will have how to deal with it? A few days ago, the reporter interviewed the pharmaceutical companies and peak health technology companies related to the person in charge. What will the Chinese Medicine Act bring us? Reporter: As the general manager of Peak Pharmaceutical, what do you think of the Chinese Medicine Law? Huang Jinlong (Deputy General Manager of the Group Company and General Manager of the Pharmaceutical Company): the Law of traditional Chinese Medicine defines the important position and development policy of traditional Chinese medicine. The state encourages traditional Chinese medicine and western medicine to learn from each other, complement each other, coordinate development, give full play to their respective advantages, and promote the integration of traditional Chinese and western medicine. Traditional Chinese medicine is a huge knowledge system, reflecting the Chinese nation's understanding of life, health and disease. It is precisely because of the distinctive characteristics of Chinese medicine that the Law of Chinese Medicine is used in Chinese medicine clinics, Chinese medicine physicians and doctors.

2020

07-31

< 1...49 50 51...61 > 跳转到页